跳至主要内容
临床试验/NCT00001254
NCT00001254已完成不适用

Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1 个研究点 分布在 1 个国家目标入组 273 人开始时间: 1991年10月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
273
试验地点
1
主要终点
To determine an approach to the localization and management of tumor in patients with ZES.

研究概览

简要总结

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

详细描述

This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).
  • Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.

排除标准

  • 未提供

研究组 & 干预措施

Patients

Patients will Zollinger-Ellison Syndrome

结局指标

主要结局

To determine an approach to the localization and management of tumor in patients with ZES.

时间窗: Yearly

localization of tumor

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验